Treatment trials for prolonged critical illness and ME/CFS (or fibromyalgia) have both independently targeted low thyroid hormone function, O&NS, and pro-inflammatory cytokines and inflammation (Figure 5). The gene discussed is TG; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.